600521 華海藥業
按盤價 
16.400 +0.220 (+1.360%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.191 | 2.905 | 13.184 | 10.631 | 16.558 |
| 總資產報酬率 ROA (%) | 1.849 | 1.276 | 5.759 | 4.519 | 6.947 |
| 投入資產回報率 ROIC (%) | 2.130 | 1.493 | 6.799 | 5.367 | 8.262 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.667 | 60.155 | 61.910 | 60.423 | 62.364 |
| 營業利潤率 (%) | 19.018 | 5.316 | 15.405 | 13.534 | 18.718 |
| 息稅前利潤/營業總收入 (%) | 23.473 | 8.059 | 16.330 | 14.895 | 18.124 |
| 淨利潤/營業總收入 (%) | 17.057 | 2.647 | 11.600 | 9.836 | 14.228 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 39.742 | 99.406 | 107.179 | 110.133 | 108.029 |
| 價值變動淨收益/利潤總額(%) | 55.797 | 15.216 | -6.710 | -14.805 | -4.639 |
| 營業外收支淨額/利潤總額(%) | 0.044 | -2.835 | -0.491 | -2.201 | -2.536 | 償債能力分析 |
| 流動比率 (X) | 1.013 | 0.959 | 1.420 | 1.400 | 1.648 |
| 速動比率 (X) | 0.612 | 0.552 | 0.848 | 0.769 | 0.945 |
| 資產負債率 (%) | 55.643 | 56.024 | 55.482 | 55.639 | 57.328 |
| 帶息債務/全部投入資本 (%) | 44.117 | 43.042 | 43.138 | 43.063 | 43.999 |
| 股東權益/帶息債務 (%) | 114.793 | 118.598 | 120.051 | 119.208 | 112.754 |
| 股東權益/負債合計 (%) | 79.657 | 78.383 | 79.152 | 78.046 | 72.520 |
| 利息保障倍數 (X) | 5.278 | 2.789 | 16.329 | 9.017 | -138.285 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 107.665 | 121.798 | 102.260 | 111.494 | 98.323 |
| 存貨周轉天數 (天) | 334.932 | 374.878 | 338.832 | 372.598 | 353.714 |
| 備註： | 即時報價更新時間為 19/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
